Meanwhile, blockade of IL4/IL4Rα-mediated mTOR signaling pathway by rapamycin treatment improved osteogenic differentiation in BMSCs, thereby rescuing the osteopenia phenotype in Fibrillin-1 (FBN1)-deficient mice (126) (Figure 1C). The gene discussed is FBN1; the disease is Osteopenia.